尿液中的葡萄糖四糖跟踪了晚发佩病的疾病活性
Cristina Domínguez-González1, Domenico Iannucci2, James Clark2
1Neuromuscular Unit, Neurology Department, Hospital 12 de Octubre, imas12 Research Institute, Madrid, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain.
Neuromuscular disorders : NMD
|February 4, 2026
概括
尿液中的葡萄糖四糖化物 (Glc4) 在晚发佩病 (LOPD) 中具有预后价值. 在LOPD患者中,基线Glc4水平较高预示着更大的功能衰退和肌肉脂肪替代.
科学领域:
- 生物化学 生物化学
- 神经学 神经学
- 代谢疾病 代谢疾病
背景情况:
- 晚期佩病 (LOPD) 是由于酸α-葡萄糖酶缺乏而导致的渐进性骨肌疾病.
- 目前用于监测LOPD进展和治疗反应的生物标志物不足.
- 尿中的葡萄糖四糖化物 (Glc4),一种糖原周转标记物,已在婴儿佩病中确立,但其在LOPD的预后效用尚不确定.
研究的目的:
- 在四年内评估LOPD患者尿液Glc4的预后值.
- 评估基线Glc4水平与功能衰退和肌肉变化的相关性.
- 确定Glc4是否可以预测LOPD临床上有意义的运动下降.
主要方法:
- 在四年内对35名LOPD患者进行长度研究,每年进行功能评估,螺旋测量和肌肉MRI.
- 尿液 Glc4 用液体染色学-并联质谱法测量,并将其正常化为肌素.
- 统计分析包括与6分钟步行测试 (6MWT),强迫生命能力 (FVC),大腿脂肪分数 (FF),ROC分析和多变量回归的关联.
主要成果:
- 在所有LOPD患者中观察到尿液Glc4水平升高,具有显著的个体内变异性.
- 较高的基线Glc4水平与6MWT的较大下降和大腿脂肪分数的增加相关.
- ROC分析表明,Glc4在识别运动衰退方面具有良好的预测性能 (AUC 0.78).
结论:
- 尿路基线Glc4为LOPD患者提供了重要的预后信息.
- Glc4是LOPD运动衰退的独立预测因子.
- 尿液Glc4可以作为常规LOPD监测的有价值的补充生物标志物.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
959
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
959
Principles of Disease Surveillance
554
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
554
Psychoneuroimmunology: Cardiovascular Disease
576
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
576


